GlaxoSmithKline Consumer Healthcare records strong growth for the quarter ended June 30, 2011. Sales rise by 22% and Profits up 15%
01 August 2011
Gurgaon, NCR, India, Aug 1, 2011
GlaxoSmithKline Consumer Healthcare Ltd. records strong growth for the quarter ended June 30, 2011
Sales up 22% and Profits up by 15%
Highlights for the quarter_______________________________________________________
Sales and Profits register strong double digit growth
The second quarter closed with 22% growth in sales and 15% in profits
Sustained focus on distribution and cost optimization drive overall growth
GlaxoSmithKline Consumer Healthcare Limited (GSKCH) recently declared its financial results for the quarter ended June 30, 2011. For the second quarter, the organization yielded an impressive sales growth of 22% over 2010 which is 8% more growth than the same period in 2010. For the second quarter, net sales were at ¬¬¬Rs 653 crs, with PBT growing by 14% to Rs. 122 crs and PAT growing by 15% to Rs.82 crs for the same period. This growth has been equally supported by contribution from all regions.
Commenting on the results,Mr. Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd.said, "Despite challenging environment of rising commodity prices and high input costs, the Company has posted excellent results."
About GlaxoSmithKline Consumer Healthcare Ltd.
GSKCH is an associate of GlaxoSmithKline plc. of U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2900 people.
GSKCH has a strong marketing and distribution network in India comprising over 550 wholesalers and direct coverage of over 6,40,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent names such as Eno, Crocin, and Iodex as well as products from the global portfolio like Breathe Right and Sensodyne.
Media Contacts _______________________________________________________________